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ABSTRACT Large outbreaks of tuberculosis (TB) represent a particular threat to disease control because
they reflect multiple instances of active transmission. The extent to which long chains of transmission
contribute to high TB incidence in London is unknown. We aimed to estimate the contribution of large
clusters to the burden of TB in London and identify risk factors.
We identified TB patients resident in London notified between 2010 and 2014, and used 24-locus
mycobacterial interspersed repetitive units–variable number tandem repeat strain typing data to classify
cases according to molecular cluster size. We used spatial scan statistics to test for spatial clustering and
analysed risk factors through multinomial logistic regression.
TB isolates from 7458 patients were included in the analysis. There were 20 large molecular clusters
(with n>20 cases), comprising 795 (11%) of all cases; 18 (90%) large clusters exhibited significant spatial
clustering. Cases in large clusters were more likely to be UK born (adjusted odds ratio 2.93, 95% CI
2.28–3.77), of black-Caribbean ethnicity (adjusted odds ratio 3.64, 95% CI 2.23–5.94) and have multiple
social risk factors (adjusted odds ratio 3.75, 95% CI 1.96–7.16).
Large clusters of cases contribute substantially to the burden of TB in London. Targeting interventions
such as screening in deprived areas and social risk groups, including those of black ethnicities and born in
the UK, should be a priority for reducing transmission.
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Introduction
In countries with low incidence of tuberculosis (TB) such as the UK, highest rates are often found in large
cities [1]. The rate of TB in London in 2014, for example, was 30 per 100000 population compared with
12 per 100000 in the whole of England [2]. This high incidence has led to the city being described as the
“TB capital of Western Europe” [3].
Large outbreaks of TB represent a particular threat to control because they reflect multiple instances of
active transmission. Such large outbreaks have occurred previously in London and other large cities [4–9].
However, identification of outbreaks of TB is difficult, as it requires cases resulting from active
transmission to be distinguished from those resulting from reactivation of latent disease with absent or
limited onward transmission. The extent to which they contribute to the overall disease burden is therefore
not known.
Molecular strain typing provides one means of linking cases that may be part of outbreaks. Cases that
share a molecular strain type may be linked through transmission and therefore form part of large
outbreaks, although they may also reflect common endemic strains. In England, prospective molecular
strain typing has been conducted since 2010 using the 24-locus mycobacterial interspersed repetitive
units–variable number tandem repeat (MIRU-VNTR) method.
Spatial analyses provide another means of investigating potential links between cases of infectious disease
[10]. Tests of spatial clustering, for example, can be used to identify cases that occur closer together in
space than would be expected by chance. They can therefore be used in combination with molecular data
to assess evidence for recent transmission in investigations of TB clusters.
An analysis of the first 3 years of MIRU-VNTR data in London showed that 46% of cases were part of a
molecular cluster and identified risk factors for clustering [11]. It also showed that cluster size ranged from
two to 55 cases, and that over half of the clusters had only two cases. However, the study did not
determine whether risk factors varied by cluster size or assess spatial clustering.
In this study, we investigated the size and distribution of molecular clusters of TB in London between
2010 and 2014 using routine molecular strain typing and epidemiological data. We aimed to quantify the
contribution of large molecular clusters to the burden of TB in the city, describe the characteristics of
cases by cluster size and identify risk factors. We also aimed to assess evidence for transmission in large
molecular clusters by testing for spatial clustering.
Methods
Study population and data sources
This was a cross-sectional analysis of patients notified with TB between January 1, 2010 and December 31,
2014 resident in London. Data were extracted from the Enhanced Tuberculosis Surveillance (ETS) system,
a national online register for real-time case reporting that is run by Public Health England (PHE). This
system includes demographic (age, sex, ethnic group, country of birth, time since entry to the UK and
occupation) and clinical (site of disease, sputum smear status, history of TB disease and treatment, drug
sensitivity, and whether the case spent time as a hospital inpatient) characteristics of patients. It also
includes patient residential locations and information on social risk factors for TB (whether the patient
has a history of homelessness, or problems with illicit drug or alcohol use). Surveillance data from ETS is
routinely matched to the National Tuberculosis Strain Typing Service to provide MIRU-VNTR molecular
clustering data.
An estimate of level of social deprivation (the index of multiple deprivation (IMD)) is also included in the
ETS system. This is obtained through matching of residential postcodes to Lower Layer Super Output
Areas (LSOAs), a geographic hierarchy used in England and Wales each encompassing a mean population
of 1500. The IMD is a measure of relative deprivation at the LSOA level in England and is based on seven
domains of deprivation: 1) income, 2) employment, 3) crime, 4) living environment, 5) barriers to housing
and services, 6) health and disability, and 7) education, skills and training [12]. Low ranks indicate higher
levels of deprivation. We converted IMD ranks into London-level deprivation quintiles, with the lowest
quintile representing the most deprived areas.
Ethical approval was not required for this study because it was based on PHE routine surveillance data.
PHE has Health Research Authority approval to hold and analyse national surveillance data for public
health purposes.
Molecular clustering analysis
We categorised cases as unique or part of a molecular cluster and by the number of cases in the molecular
cluster. We used the PHE convention for assigning cluster status. Molecular clusters were groups of two or
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more cases that shared an identical MIRU-VNTR strain type with another case notified in the study
region during the study period. Unique cases were individuals whose strain type did not cluster with
another case. We excluded cases who did not have an isolate typed by MIRU-VNTR with at least 23 loci
and those whose molecular strain type was unique within the study area but shared a molecular strain type
with another case in England.
We described the distribution of molecular clusters by size (number of cases in the cluster) and calculated
the proportion of cases which were part of clusters. We identified successive cases reported in a molecular
cluster using case notification dates and calculated the median and interquartile range (IQR) number of
days between successive cases in molecular clusters by cluster size.
In this analysis, we aimed to investigate risk factors for cases belonging to a molecular clusters of different
sizes. We therefore categorised cases according to the size of the molecular cluster (not clustered (unique)
cases, n=2 cases, n=3–20 cases and n>20 cases). In situations such as this, in which the outcome of
interest is a categorical variable, a multinomial logistic regression model can be used [13]. This is an
extension of the simple logistic regression model which is used for dichotomous outcomes. Coefficients
resulting from the multinomial model are interpreted in a similar way to the odds ratios (ORs) derived
from a logistic regression model.
We investigated associations at single-variable analysis and included variables with an association of p<0.2
in the initial multivariable model. A backwards stepwise approach was then used to eliminate variables
which did not contribute significantly to produce a final model. LSOA of residence was included as a
random effect in models which included the IMD to account for the hierarchical level at which this
variable was measured. Social risk factors were considered separately, and as a cumulative count of these
risk factors at single-variable analysis and as a count at multivariable analysis.
Spatial clustering analysis
We used spatial scan statistics to assess spatial clustering within molecular clusters, implemented using
SaTScan software (www.satscan.org). We tested the hypothesis that cases in large molecular clusters (n>20
cases) were closer together in space than the underlying spatial distribution of TB cases. For each large
molecular cluster, we therefore performed a spatial scan under the Bernoulli (case–control) model, using
the locations of all other TB cases as controls.
We aimed to identify areas with evidence of local transmission and therefore set the maximum radius of
the spatial window at 5 km and identified clusters with a p-value of <0.05 which encompassed at least 10
cases. We plotted the locations of significant spatial clusters for each molecular cluster overlaid on a
smoothed incidence map of the relative distribution of the given molecular cluster compared with all other
TB cases. These maps were generated through kernel density estimation using a Gaussian kernel of
bandwidth 5 km.
Statistical analyses were performed using R version 3.2.3 (www.r-project.org).
Results
Between 2010 and 2014, a total of 15670 cases of TB were notified in London. Of these, 8148 (52%) cases
were successfully typed by MIRU-VNTR with at least 23 loci defined, whilst 6241 (40%) were not culture
confirmed and 1281 (8%) were not typed, and therefore excluded from this analysis (figure 1). A further
690 cases were also excluded because they clustered only with cases that were not resident within the study
FIGURE 1 Cases included in
analysis of molecular clusters of
tuberculosis in London (2010–2014).
15 670 tuberculosis cases
6241 not culture conﬁrmed
1281 not typed to at least 23 loci
690 clustered only with
cases outside study area
7458 cases included
3329 unique strains
(not clustered)
4129 in 
molecular clusters
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area. This study therefore included 7458 TB cases with a molecular strain type, of which 4129 (55%) were
part of 996 molecular clusters and 3329 (45%) had a unique strain.
Cluster size and time between cases
Cluster size ranged from two to 102 cases, with a median of n=2 cases. There were 20 clusters with n>20
cases, including 795 (11%) of all cases (table 1). Over half of the clusters (522 (53%)) comprised pairs of
cases, but a larger proportion of cases were in the 454 clusters of n=3–20 cases (2290 (31% of cases)).
Successive cases in clusters were defined using notification dates. Figure 2 displays the distribution of
median intervals between successive cases in each cluster by cluster size. Overall, the median (IQR) time
between successive cases in a cluster was 114 (32–323) days. For cases in clusters of n>20 cases the median
(IQR) time was 23 (8–54) days, for cases in clusters of n=3–20 cases it was 149 (54–335) days) and for
clusters of n=2 cases it was 406 (162–752) days.
Factors associated with large clusters
Baseline characteristics of TB cases according to the number of cases in the cluster are shown in table 2
and results of the single-variable multinomial logistic regression analysis are presented in table 3.
For each exposure, an OR was calculated for each of the three cluster size outcomes (n=2, 3–20 and >20
cases), with cases not in a cluster representing the comparison group. For example, the unadjusted ORs for
being born in the UK were 4.11 (for cases in clusters of n>20 cases), 2.55 (for cases in clusters of n=3–20
cases) and 1.77 (for cases in clusters of n=2 cases). This means that the odds of cases being in the largest
clusters versus not being in a cluster for those born in the UK were 4.11 times that of those not born in
0
0
10
20
30
40
50
60
70
80
90
100
110
250 500
Median interval between successive cases in molecular clusters days
M
ol
ec
ul
ar
 c
lu
st
er
s 
n
750 1000 1250 1500
Cases in molecular 
cluster n:
2
3–20
>20
1750
FIGURE 2 Median interval between successive tuberculosis cases in molecular clusters in London
(2010–2014), by cluster size.
TABLE 1 Distribution of tuberculosis cases and molecular clusters in London (2010–2014),
by cluster size
Cases in cluster Cases Clusters
1 (not clustered) 3329 (44.6)
2 1044 (14.0) 522 (52.4)
3–20 2290 (30.7) 454 (45.6)
>20 795 (10.7) 20 (2.0)
Total 7458 (100) 996 (100)
Data are presented as n (%).
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TABLE 2 Baseline characteristics of tuberculosis cases in molecular clusters of different sizes
in London (2010–2014)
All cases Not clustered Cases in cluster n
2 3–20 >20
Sex
Female 2911 1320 (45.3) 430 (14.8) 874 (30.0) 287 (9.9)
Male 4546 2008 (44.2) 614 (13.5) 1416 (31.1) 508 (11.2)
Age group years
0–14 158 43 (27.2) 24 (15.2) 60 (38.0) 31 (19.6)
15–44 5284 2346 (44.4) 731 (13.8) 1628 (30.8) 579 (11.0)
45–64 1369 585 (42.7) 207 (15.1) 433 (31.6) 144 (10.5)
⩾65 647 355 (54.9) 82 (12.7) 169 (26.1) 41 (6.3)
Ethnic group
White 829 308 (37.2) 119 (14.4) 277 (33.4) 125 (15.1)
Black-Caribbean 258 49 (19.0) 38 (14.7) 113 (43.8) 58 (22.5)
Black-African 1722 609 (35.4) 242 (14.1) 614 (35.7) 257 (14.9)
Black-Other 97 28 (28.9) 15 (15.5) 37 (38.1) 17 (17.5)
Indian 2185 1126 (51.5) 303 (13.9) 615 (28.1) 141 (6.5)
Pakistani 673 313 (46.5) 96 (14.3) 181 (26.9) 83 (12.3)
Bangladeshi 365 246 (67.4) 38 (10.4) 69 (18.9) 12 (3.3)
Chinese 86 49 (57.0) 11 (12.8) 21 (24.4) 5 (5.8)
Mixed/other 1177 561 (47.7) 176 (15.0) 347 (29.5) 93 (7.9)
Place of birth
Non-UK 6223 2990 (48.0) 876 (14.1) 1801 (28.9) 556 (8.9)
UK 1150 301 (26.2) 156 (13.6) 463 (40.3) 230 (20.0)
Time since entry to UK years
0–1 1095 540 (49.3) 159 (14.5) 298 (27.2) 98 (9.0)
2–4 1391 740 (53.2) 202 (14.5) 347 (24.9) 102 (7.3)
5–9 1156 538 (46.5) 162 (14.0) 339 (29.3) 117 (10.1)
⩾10 1803 785 (43.5) 261 (14.5) 583 (32.3) 174 (9.7)
Occupation
Other 2465 1146 (46.5) 342 (13.9) 759 (30.8) 218 (8.8)
None 2615 1129 (43.2) 367 (14.0) 788 (30.1) 331 (12.7)
Education 1074 452 (42.1) 148 (13.8) 342 (31.8) 132 (12.3)
Healthcare 275 137 (49.8) 44 (16.0) 81 (29.5) 13 (4.7)
Pulmonary disease
No 3006 1553 (51.7) 389 (12.9) 815 (27.1) 249 (8.3)
Yes 4452 1776 (39.9) 655 (14.7) 1475 (33.1) 546 (12.3)
Sputum smear
Negative 2371 1066 (45.0) 338 (14.3) 734 (31.0) 233 (9.8)
Positive 2062 745 (36.1) 314 (15.2) 718 (34.8) 285 (13.8)
Previous diagnosis
No 6821 3088 (45.3) 941 (13.8) 2078 (30.5) 714 (10.5)
Yes 354 124 (35.0) 57 (16.1) 125 (35.3) 48 (13.6)
Previous treatment
No 13 6 (46.2) 1 (7.7) 6 (46.2)
Yes 261 82 (31.4) 41 (15.7) 98 (37.5) 40 (15.3)
Drug resistance#
No 6738 3033 (45.0) 921 (13.7) 2114 (31.4) 670 (9.9)
Yes 667 276 (41.4) 111 (16.6) 161 (24.1) 119 (17.8)
Inpatient
No 4649 2100 (45.2) 636 (13.7) 1441 (31.0) 472 (10.2)
Yes 2731 1190 (43.6) 397 (14.5) 831 (30.4) 313 (11.5)
Homeless
No 6917 3116 (45.0) 969 (14.0) 2135 (30.9) 697 (10.1)
Yes 294 96 (32.7) 44 (15.0) 85 (28.9) 69 (23.5)
Drug use
No 6822 3110 (45.6) 967 (14.2) 2079 (30.5) 666 (9.8)
Yes 307 75 (24.4) 30 (9.8) 111 (36.2) 91 (29.6)
Continued
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TABLE 2 Continued
All cases Not clustered Cases in cluster n
2 3–20 >20
Alcohol use
No 6460 2911 (45.1) 908 (14.1) 1979 (30.6) 662 (10.2)
Yes 328 106 (32.3) 42 (12.8) 124 (37.8) 56 (17.1)
Prison
No 6938 3140 (45.3) 984 (14.2) 2129 (30.7) 685 (9.9)
Yes 225 53 (23.6) 22 (9.8) 78 (34.7) 72 (32.0)
Risk factor count¶
0 6688 3081 (46.1) 950 (14.2) 2020 (30.2) 637 (9.5)
1 508 187 (36.8) 64 (12.6) 180 (35.4) 77 (15.2)
2 159 41 (25.8) 19 (12.0) 58 (36.5) 41 (25.8)
3 84 19 (22.6) 8 (9.5) 26 (31.0) 31 (36.9)
4 19 1 (5.3) 3 (15.8) 6 (31.6) 9 (47.4)
Mean IMD quintile+ 2.45 2.40 2.41 2.15
Data are presented as n or n (% row). IMD: index of multiple deprivation. #: resistance to any first-line
antibiotic; ¶: cumulative number of social risk factors (history of homelessness, illicit drug use, alcohol
misuse, imprisonment) reported by each case; +: IMD quintile of Lower Layer Super Output Area within
London (lowest is most deprived).
TABLE 3 Single-variable multinomial logistic regression analysis for risk factors associated
with tuberculosis cases in molecular clusters of different sizes in London (2010–2014)
Cases in cluster n
2 3–20 >20
Sex
Female 1 1 1
Male 0.94 (0.81–1.08) 1.07 (0.95–1.19) 1.16 (0.99–1.37)#
Age group years
0–14 1.79 (1.08–2.97)# 2.01 (1.35–2.99)# 2.92 (1.82–4.68)#
15–44 1 1 1
45–64 1.14 (0.95–1.36)# 1.07 (0.93–1.23) 1.00 (0.81–1.22)#
⩾65 0.74 (0.57–0.96)# 0.69 (0.57–0.83)# 0.47 (0.33–0.65)#
Ethnic group
White 1 1 1
Black-Caribbean 2.01 (1.25–3.22)# 2.56 (1.77–3.72)# 2.92 (1.89–4.50)#
Black-African 1.03 (0.79–1.33) 1.12 (0.92–1.37) 1.04 (0.81–1.34)#
Black-Other 1.39 (0.72–2.69) 1.47 (0.88–2.46)# 1.50 (0.79–2.83)#
Indian 0.70 (0.54–0.89)# 0.61 (0.50–0.73)# 0.31 (0.24–0.40)#
Pakistani 0.79 (0.58–1.08)# 0.64 (0.50–0.82)# 0.65 (0.47–0.90)#
Bangladeshi 0.40 (0.27–0.60)# 0.31 (0.23–0.43)# 0.12 (0.06–0.22)#
Chinese 0.58 (0.29–1.16)# 0.48 (0.28–0.81)# 0.25 (0.10–0.65)#
Mixed/other 0.81 (0.62–1.06)# 0.69 (0.56–0.85)# 0.41 (0.30–0.55)#
Place of birth
Non-UK 1 1 1
UK 1.77 (1.44–2.18)# 2.55 (2.18–2.99)# 4.11 (3.38–4.99)#
Time since entry to UK years
0–1 1 1 1
2–4 0.93 (0.73–1.17) 0.85 (0.70–1.03)# 0.76 (0.56–1.02)#
5–9 1.02 (0.80–1.31) 1.14 (0.94–1.39)# 1.20 (0.89–1.61)
⩾10 1.13 (0.90–1.41) 1.35 (1.13–1.61)# 1.22 (0.93–1.60)#
Occupation
Other 1 1 1
None 1.09 (0.92–1.29) 1.05 (0.93–1.20) 1.54 (1.27–1.86)#
Education 1.10 (0.88–1.37) 1.14 (0.97–1.35)# 1.54 (1.21–1.96)#
Healthcare 1.08 (0.75–1.54) 0.89 (0.67–1.19) 0.50 (0.28–0.90)#
Continued
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the UK. Similarly, the odds of cases being in a cluster of n=2–20 cases compared with not being in a
cluster for those born in the UK were 2.55 times that of those not born in the UK; and the odds of cases
being in a cluster of n=2 cases compared with not being in a cluster for those born in the UK were 1.77
times those not born in the UK.
Factors included in the final multivariable model were sex, age, ethnicity, place of birth, occupation, site of
disease, drug resistance, number of social risk factors and IMD (table 4 and figure 3). Cases in the oldest
age group (⩾65 years) had an adjusted OR (aOR) of 0.52 (95% CI 0.35–0.78); aOR for being born in the
UK was 2.93 (95% CI 2.28–3.77). The association between black ethnic groups and larger cluster size was
maintained (aOR black-Caribbean ethnicity 3.64, 95% CI 2.23–5.94), whilst the only ethnic group with
significantly lower risk than the white population was Bangladeshi (aOR 0.26, 95% CI 0.13–0.50). Students
and those working in education had an increased adjusted odds of being in large clusters (aOR 1.31, 95%
CI 1.01–1.70), and those working in healthcare had a decreased adjusted odds (aOR 0.47, 95% CI
0.25–0.87).
TABLE 3 Continued
Cases in cluster n
2 3–20 >20
Pulmonary disease
No 1 1 1
Yes 1.47 (1.28–1.70)# 1.58 (1.42–1.77)# 1.92 (1.63–2.26)#
Sputum smear
Negative 1 1 1
Positive 1.33 (1.11–1.59)# 1.40 (1.22–1.61)# 1.75 (1.44–2.13)#
Previous diagnosis
No 1 1 1
Yes 1.51 (1.09–2.08)# 1.50 (1.16–1.93)# 1.67 (1.19–2.35)#
Previous treatment
No 1 1 1
Yes 3.03 (0.35–26.12) 1.20 (0.37–3.86)
Drug resistance¶
No 1 1 1
Yes 1.32 (1.05–1.67)# 0.84 (0.68–1.02)# 1.95 (1.55–2.46)#
Inpatient
No 1 1 1
Yes 1.10 (0.95–1.27)# 1.02 (0.91–1.14) 1.17 (1.00–1.37)#
Homeless
No 1 1 1
Yes 1.47 (1.02–2.12)# 1.29 (0.96–1.74)# 3.21 (2.33–4.43)#
Drug use
No 1 1 1
Yes 1.29 (0.84–1.98) 2.21 (1.64–2.98)# 5.67 (4.13–7.78)#
Alcohol use
No 1 1 1
Yes 1.27 (0.88–1.83)# 1.72 (1.32–2.24)# 2.32 (1.66–3.25)#
Prison
No 1 1 1
Yes 1.32 (0.80–2.19) 2.17 (1.52–3.09)# 6.22 (4.32–8.95)#
Risk factor count+
0 1 1 1
1 1.11 (0.83–1.49) 1.47 (1.19–1.82)# 1.99 (1.51–2.63)#
2 1.50 (0.87–2.60)# 2.16 (1.44–3.23)# 4.84 (3.11–7.52)#
3 1.37 (0.60–3.13) 2.09 (1.15–3.78)# 7.89 (4.43–14.06)#
4 9.73 (1.01–93.64)# 9.15 (1.10–76.07)# 43.53 (5.51–344.20)#
IMD quintile§ 0.59 (0.54–0.63)# 0.86 (0.81–0.91)# 0.62 (0.57–0.68)#
Data are presented as adjusted odds ratio (95% CI). IMD: index of multiple deprivation. #: p<0.2, included
in initial multivariable model. ¶: resistance to any first-line antibiotic; +: cumulative number of social risk
factors (history of homelessness, illicit drug use, alcohol misuse, imprisonment) reported by each case;
§: IMD quintile of Lower Layer Super Output Area (LSOA) within London (lowest is most deprived), included
as a continuous variable in multilevel model accounting for random effects of LSOA.
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Social risk factors were included in the final model as a count and there was a trend of increased odds
with increased number of risk factors, although confidence intervals overlapped (aOR three risk factors
3.75, 95% CI 1.96–7.16; aOR four risk factors 16.64, 95% CI 1.98–139.88). Deprivation was also
independently associated with being in a large cluster; the aOR was 0.90 (95% CI 0.83–0.97) for increased
IMD quintile and therefore decreased deprivation level.
Black-Caribbean ethnicity, being born in the UK and pulmonary disease were the only factors that also
had significantly elevated odds for clusters of n=2 or n=3–20 cases.
Spatial clusters of cases in large molecular clusters
We used SaTScan to test for spatial clustering in the 20 molecular clusters that had n>20 cases. A total of
25 significant spatial clusters (p<0.05) were identified, with at least one significant spatial cluster in 18
TABLE 4 Multivariable multinomial logistic regression analysis for risk factors associated with
tuberculosis cases in molecular clusters of different sizes in London (2010–2014), adjusted for
random effects of Lower Layer Super Output Area (LSOA)
Cases in cluster n
2 3–20 >20
Sex
Female 1 1 1
Male 0.98 (0.83–1.16) 1.08 (0.95–1.23) 1.14 (0.94–1.38)
Age group years
0–14 1.15 (0.65–2.02) 1.18 (0.76–1.83) 1.29 (0.75–2.22)
15–44 1 1 1
45–64 1.13 (0.92–1.39) 0.97 (0.82–1.15) 0.82 (0.64–1.04)
⩾65 0.68 (0.50–0.93) 0.71 (0.56–0.90) 0.52 (0.35–0.78)
Ethnic group
White 1 1 1
Black-Caribbean 2.1 (1.25–3.55) 3.13 (2.08–4.71) 3.64 (2.23–5.94)
Black-African 1.35 (0.99–1.86) 1.86 (1.46–2.38) 2.09 (1.49–2.91)
Black-Other 1.88 (0.92–3.84) 1.92 (1.07–3.45) 2.29 (1.13–4.66)
Indian 0.95 (0.70–1.30) 1.02 (0.80–1.30) 0.78 (0.55–1.11)
Pakistani 1.08 (0.75–1.55) 1.02 (0.76–1.36) 1.51 (1.02–2.24)
Bangladeshi 0.60 (0.38–0.94) 0.53 (0.37–0.76) 0.26 (0.13–0.50)
Chinese 0.78 (0.37–1.64) 0.78 (0.44–1.40) 0.63 (0.24–1.68)
Mixed/other 1.12 (0.81–1.54) 1.11 (0.86–1.43) 0.89 (0.61–1.29)
Place of birth
Non-UK 1 1 1
UK 1.45 (1.12–1.87) 2.13 (1.75–2.58) 2.93 (2.28–3.77)
Occupation
Other 1 1 1
None 1.04 (0.85–1.27) 0.96 (0.82–1.12) 1.18 (0.94–1.49)
Education 1.04 (0.82–1.31) 1.04 (0.87–1.24) 1.31 (1.01–1.70)
Healthcare 1.00 (0.69–1.45) 0.82 (0.60–1.11) 0.47 (0.25–0.87)
Pulmonary disease
No 1 1 1
Yes 1.46 (1.24–1.72) 1.48 (1.30–1.68) 1.47 (1.21–1.79)
Drug resistance#
No 1 1 1
Yes 1.25 (0.96–1.61) 0.82 (0.65–1.03) 1.75 (1.34–2.28)
Risk factor count¶
0 1 1 1
1 0.83 (0.59–1.15) 1.12 (0.88–1.42) 1.36 (0.99–1.87)
2 1.00 (0.53–1.89) 1.59 (1.00–2.52) 2.46 (1.45–4.18)
3 0.86 (0.35–2.12) 1.28 (0.67–2.45) 3.75 (1.96–7.16)
4 4.35 (0.39–48.50) 4.13 (0.45–37.58) 16.64 (1.98–139.88)
IMD quintile+ 0.98 (0.91–1.04) 1.00 (0.95–1.06) 0.90 (0.83–0.97)
Data are presented as adjusted odds ratio (95% CI). IMD: index of multiple deprivation. #: resistance to any
first-line antibiotic; ¶: cumulative number of social risk factors (history of homelessness, illicit drug use,
alcohol misuse, imprisonment) reported by each case; +: IMD quintile of LSOA within London (lowest is most
deprived), included as a continuous variable in multilevel model accounting for random effects of LSOA.
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(90%) of the molecular clusters, and eight of the spatial clusters included more than 10 cases. These
clusters tended to be located in more deprived areas; the median IMD rank of the 4970 LSOAs within
London for areas within the clusters was 1110 compared with 2538.5 for areas not in clusters.
The locations of the eight spatial clusters, overlaid on smoothed incidence maps, are shown in figure 4.
Discussion
In this study, we present results from the first 5 years of routine molecular strain typing of TB by
MIRU-VNTR in London. There were 20 molecular clusters that had n>20 cases of TB notified between
2010 and 2014. These clusters accounted for 795 (11%) of all typed cases notified during this period, and
cases in large clusters also tended to occur closer together in space and time. One of the molecular clusters
described in this study is part of a known outbreak of isoniazid-resistant disease that was first identified in
1999 [5], but this is the first analysis to suggest that multiple similar outbreaks may be ongoing.
Cases in large molecular clusters were more likely to have multiple social risk factors, be of black
ethnicities, born in the UK, have pulmonary and drug-resistant disease, and live in more deprived areas of
London. Small clusters (pairs of cases) and those of intermediate size (n=3–20 cases) were associated with
black-Caribbean ethnicity, being born in the UK and pulmonary disease. There was also some association
between large clusters and occupation. Large clusters were more likely to include students and those
involved in education, which may suggest that outbreaks in schools and universities can spread widely in
these settings or through extensive social networks involving students. However, they were less likely to
involve healthcare workers. This indicates that there was limited nosocomial transmission and that when
transmission involving a healthcare worker did occur it was usually an isolated incident rather than part of
a large outbreak.
0 1 2 3 4 5 6
Adjusted odds ratio
7
Male
a) b) c)
0–14 years
45–64 years
≥65 years
Black-Caribbean
Black-Other
Black-African
Pakistani
Mixed/other
Indian
Chinese
Bangladeshi
UK born
Occupation: None
Occupation: Education
Occupation: Healthcare
Pulmonary disease
Drug resistance
Risk factors: 3
Risk factors: 2
Risk factors: 1
IMD quintile
0 1 2 3 4 5 6 7 0 1 2 3 4 5 6 7
FIGURE 3 Forest plot of adjusted odds ratios (with 95% confidence intervals) from multivariable multinomial logistic regression analysis (table 4),
by number of cases in molecular cluster: a) n=2, b) n=3–20 and c) n>20 cases.
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The majority of large molecular clusters exhibited significant spatial clustering, indicating likely
transmission within London. Spatial clusters tended to be in more deprived areas and the IMD was
independently associated with being in a large molecular cluster, after accounting for individual risk
factors. Studies in other settings, including Lima, Peru [14], northern England [15], Tokyo, Japan [16] and
the USA [17], have also investigated TB clustering using molecular and spatial data. Various methods have
been used to assess spatial clustering, but all have also identified areas of likely localised TB transmission
or “hotspots”.
Previous analyses of MIRU-VNTR strain typing and surveillance data in various settings have sought to
determine the proportion of cases that were part of a molecular cluster or to identify risk factors for
clustering [11, 18–25]. A systematic review of 27 articles found that clustering estimates ranged from 0% to
63% [26], whilst the clustering proportion in the first 3 years of routine molecular strain typing in London
was 46% [11]. This indicates that the rate of molecular clustering identified in our analysis (56%) was
relatively high and that it has risen with inclusion of more years of data.
a) b)
c) d)
e) f)
g) h)
Proportion of tuberculosis cases 
in molecular cluster (quintile):
1 2 3 4 5
0 5 10 km
FIGURE 4 a–h) Locations of significant spatial clusters of cases within eight molecular clusters of
tuberculosis (TB) in London (2010–2014), overlaid on smoothed incidence maps. Ovals represent areas of
significant spatial clustering (p<0.05) with more than 10 cases of the given molecular cluster compared with
the general distribution of TB cases. The proportions of cases in molecular clusters compared with all other
TB cases are represented through kernel density estimation (bandwidth 5 km).
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A strength of this study was that it was based on routine surveillance data and therefore included all cases
of TB in London that were successfully typed by MIRU-VNTR to at least 23 loci over a 5-year period.
There was a low level of missing information in the variables used in the risk factor analysis (table 2). As a
result it provides a good representation of the population of TB cases in the city. The study adhered to the
STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines for reporting
of cross-sectional studies [27].
Another strength was the use of multinomial logistic regression to identify risk factors. The advantage of
this method was that it allowed associations to be assessed for different sizes of molecular cluster. This is
important because larger clusters have more implications for TB control. It therefore extended the
previous analysis of risk factors for clustering, which used a binary outcome that was not stratified by
cluster size. The combination of molecular with spatial clustering analyses was a further advantage of this
study, as it provided further evidence for transmission in some large molecular clusters. It also has
practical application, as it could be used to prioritise clusters for further investigation.
A limitation of this study is that we had to restrict our analysis to cases of TB which had been typed by
MIRU-VNTR for at least 23 loci. We therefore excluded 7522 cases that were not culture confirmed or
typed. This will have resulted in misclassification of some cases as unclustered which did not have a
unique strain and therefore underestimated the number of cases in some clusters. A second limitation was
that we considered the temporal distribution of cases in molecular clusters by examining the median
interval between case notification dates, which are a proxy for dates of onset. This provided some evidence
that cases in larger molecular clusters occurred closer together in time than those in smaller clusters.
However, a true estimate of serial intervals to assess this robustly would require ascertainment of
epidemiological links between cases to establish chains of transmission. Our analysis was also limited
because we were unable to assess the importance of other potential factors affecting TB transmission
which are not currently collected in surveillance data. HIV status, for example, is not routinely collected,
although all TB patients are offered HIV testing and it was taken up by 98% patients in London in 2014
[28]. Modelling estimates show that HIV co-infection in TB patients in England is relatively low, at just
3.4% in 2014 (personal communication, PHE National Infection Service).
The results of this study have implications for the control of TB in London and other high-incidence
cities. Targeting interventions to deprived areas should be a priority for reducing transmission, whilst
efforts should also be made to raise awareness of the disease amongst at-risk groups, such as those of black
ethnicities born in the UK. An example of such an intervention is the “Find and Treat” mobile
radiography unit which actively screens for cases in vulnerable populations in London and provides
support to help patients complete treatment [29]. Continued support for this service is therefore a key
component of TB control in London. Our results also imply that detailed investigations of molecular
clusters could be beneficial in preventing large chains of transmission through interventions such as
contact tracing and screening. We recommend incorporating routine spatial clustering analysis to assist
with prioritising clusters for further investigation, as use of simple thresholds has previously been
ineffective in making these decisions [30, 31].
Future work arising from this study could aim to identify which of the components of the IMD may be
contributing to TB transmission. This would be useful to inform environmental and housing
interventions, such as improving ventilation and reducing overcrowding. More work is also required to
determine if the associations observed in clusters of different sizes could be used to predict whether cases
in small clusters are likely to form larger clusters. Finally, results from whole genome sequencing of TB
isolates when routinely available should add further resolution to networks suggested by molecular
clusters. This could provide evidence to support or refute transmission in some instances and direct the
focus of intensive investigations [32].
In conclusion, this study shows that large molecular clusters contribute substantially to the burden of TB
in London. The results highlight the continued importance of preventing long chains of transmission in
order to eliminate TB as a public health problem in large cities.
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